BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17709887)

  • 1. Deleting islet autoimmunity.
    Liu E; Li M; Jasinski J; Kobayashi M; Gianani R; Nakayama M; Eisenbarth GS
    Cell Biochem Biophys; 2007; 48(2-3):177-82. PubMed ID: 17709887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology: Insulin auto-antigenicity in type 1 diabetes.
    Wilson DB
    Nature; 2005 Nov; 438(7067):E5; discussion E5-6. PubMed ID: 16306940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
    Wang B; Tisch R
    Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin as a key autoantigen in the development of type 1 diabetes.
    Nakayama M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):773-7. PubMed ID: 22069258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
    Mannering SI; Rubin AF; Wang R; Bhattacharjee P
    Front Immunol; 2021; 12():667870. PubMed ID: 33995402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
    Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
    Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune islet damage mediated by insulin-specific T cells.
    Crawford M; Daniel D; Wegmann D; Yang H; Gill RG
    Transplant Proc; 1997; 29(1-2):758-9. PubMed ID: 9123512
    [No Abstract]   [Full Text] [Related]  

  • 12. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
    Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
    Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease prevention with islet autoantigens.
    Eisenbarth GS; Jasinski JM
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):59-73, viii. PubMed ID: 15053895
    [No Abstract]   [Full Text] [Related]  

  • 16. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
    Wang J; Tsai S; Shameli A; Yamanouchi J; Alkemade G; Santamaria P
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9317-22. PubMed ID: 20439719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update.
    Wan X; Unanue ER
    Curr Opin Immunol; 2017 Jun; 46():30-37. PubMed ID: 28456018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
    Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
    Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.